Arrowhead Pharmaceuticals, Inc. (0HI3.L) LSE

70.73

+2.2009(+3.21%)

Updated at December 24 05:29PM

Currency In USD

Valuation

Market Cap4.61B
Enterprise Value4.64B
P/E Ratio-65.68
PEG Ratio-7.61
Price/Sales Ratio16.25
Price/Book Ratio18.75
Enterprise/Revenue17.23
Enterprise/EBITDA-195.73

Fiscal Year

Fiscal YearSeptember 30, 2025
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.25
Operating Margin-0.18

Management Effectiveness

Return On Assets-0.11
Return On Equity-0.41

Income Statement

Revenue829.45M
Revenue/Share4.29
Gross Profit0
EBITDA98.35M
Net Income-1.63M
Diluted EPS-0.01

Balance Sheet

Total Cash900.37M
Total Cash/Share6.48
Total Debt713.29M
Total Debt/Equity1.37
Current Ratio4.87
Book Value Per Share3.74

Price History

52-Week Change272.25
52-Week High71.3
52-Week Low20.75
Moving Average 50 Days32.83
Moving Average 200 Days31.06

Statistics

Average Volume1,779
Shares Outstanding135.8M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A